Recruiting
Phase 1

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

Sponsor:

UNC Lineberger Comprehensive Cancer Center

Code:

NCT03602157

Conditions

Lymphoma

Immune System Diseases

Immunoproliferative Disorders

Lymphatic Diseases

Lymphoproliferative Disorders

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ATLCAR.CD30.CCR4 cells

ALTCAR.CD30 cells

Bendamustine

Fludarabine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information